Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A one year, parallel, placebo-controlled, double-blind, randomized study to assess the effect of monthly 150mg oral ibandronate dosing versus placebo on bone quality and strength at the proximal femur in women with osteoporosis
ibandronic acid
BON103593
NCT00148915
Osteoporosis
Phase 4
 
July 2015

Powered by ideaPoint, Inc.